189 related articles for article (PubMed ID: 15371950)
1. OCT4: a novel biomarker for dysgerminoma of the ovary.
Cheng L; Thomas A; Roth LM; Zheng W; Michael H; Karim FW
Am J Surg Pathol; 2004 Oct; 28(10):1341-6. PubMed ID: 15371950
[TBL] [Abstract][Full Text] [Related]
2. [Expression and diagnostic significance of OCT4, CD117 and CD30 in germ cell tumors].
Teng LH; Lu DH; Xu QZ; Fu YJ; Yang H; He ZL
Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):711-5. PubMed ID: 16536313
[TBL] [Abstract][Full Text] [Related]
3. FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas.
Buell-Gutbrod R; Ivanovic M; Montag A; Lengyel E; Fadare O; Gwin K
Pediatr Dev Pathol; 2011; 14(5):391-5. PubMed ID: 21682576
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
5. OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma.
Hattab EM; Tu PH; Wilson JD; Cheng L
Am J Surg Pathol; 2005 Mar; 29(3):368-71. PubMed ID: 15725806
[TBL] [Abstract][Full Text] [Related]
6. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
[TBL] [Abstract][Full Text] [Related]
8. Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary.
Pauls K; Franke FE; Büttner R; Zhou H
Virchows Arch; 2005 Sep; 447(3):603-9. PubMed ID: 15968543
[TBL] [Abstract][Full Text] [Related]
9. Expression of SALL4 and SF-1 in gonadoblastoma: useful markers in the identification of the invasive germ cell component.
Bai S; Wei S; Ziober A; Yao Y; Bing Z
Int J Gynecol Pathol; 2013 Jul; 32(4):379-83. PubMed ID: 23722510
[TBL] [Abstract][Full Text] [Related]
10. Differentiation potential of ovarian dysgerminoma: an immunohistochemical study of 15 cases.
Lifschitz-Mercer B; Walt H; Kushnir I; Jacob N; Diener PA; Moll R; Czernobilsky B
Hum Pathol; 1995 Jan; 26(1):62-6. PubMed ID: 7821917
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.
Trinh DT; Shibata K; Hirosawa T; Umezu T; Mizuno M; Kajiyama H; Kikkawa F
J Obstet Gynaecol Res; 2012 May; 38(5):841-8. PubMed ID: 22448662
[TBL] [Abstract][Full Text] [Related]
12. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
13. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Cytokeratin and CD30 expression in dysgerminoma.
Cossu-Rocca P; Jones TD; Roth LM; Eble JN; Zheng W; Karim FW; Cheng L
Hum Pathol; 2006 Aug; 37(8):1015-21. PubMed ID: 16867864
[TBL] [Abstract][Full Text] [Related]
16. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
17. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
18. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.
Obata NH; Nakashima N; Kawai M; Kikkawa F; Mamba S; Tomoda Y
Gynecol Oncol; 1995 Jul; 58(1):124-8. PubMed ID: 7789879
[TBL] [Abstract][Full Text] [Related]
19. Increasing expression of extracellular matrix metalloprotease inducer in ovary tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Yao CW; Loh SH; Cheng MF; Hsieh DS; Bai CY
Int J Gynecol Pathol; 2006 Apr; 25(2):140-6. PubMed ID: 16633062
[TBL] [Abstract][Full Text] [Related]
20. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors.
Looijenga LH; Stoop H; de Leeuw HP; de Gouveia Brazao CA; Gillis AJ; van Roozendaal KE; van Zoelen EJ; Weber RF; Wolffenbuttel KP; van Dekken H; Honecker F; Bokemeyer C; Perlman EJ; Schneider DT; Kononen J; Sauter G; Oosterhuis JW
Cancer Res; 2003 May; 63(9):2244-50. PubMed ID: 12727846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
